Can we predict the risk factors for switching due to ineffectiveness in the first year of therapy with bDMARD in patients with rheumatoid arthritis? Ana Martins, Sofia Pimenta, Daniela Oliveira, Rafaela Nicolau, Alexandra Bernardo, Teresa Martins Rocha, Lúcia Costa, Miguel Bernardes

Ocular inflammatory manifestations in patients with rheumatoid arthritis Raul E. Ruiz-Lozano, Luis Arnaldo Prida-Espaillat, Reinaldo A. Moll-Auais, Eugenia M. Ramos-Dávila, Manuel E. Quiroga-Garza, Aaron Zhao, Ali Khodor, Amr Almobayed, David Vega-Morales, Alejandro Rodriguez-Garcia

Coexistence of Sarcoidosis and Gouty Arthritis Hüseyin Semiz, Senol Kobak